Author Question: This threat to external validity occurs when a pretest sensitizes participants to the treatment yet ... (Read 29 times)

mmm

  • Hero Member
  • *****
  • Posts: 558
This threat to external validity occurs when a pretest sensitizes participants to the treatment yet
  to come.
 
  A) interaction of testing and treatment B) interaction of selection and treatment
  C) multiple-treatment interference D) reactive arrangements

Question 2

For each of the following designs, list the number of IVs and the number of levels for
  each specific IV:
  a. 2  2
  b. 2  4
  c. 3  2  2
  d. 2  3  4
  e. 2  2  2  2
 
  What will be an ideal response?



ergserg

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

A

Answer to Question 2

a: 2 IVs; 2 levels for the first IV; 2 levels for the second IV
b: 2 IVs; 2 levels for the first IV; 4 levels for the second IV
c: 3 IVs; 3 levels for the first IV; 2 levels for the second IV; 2 levels for the third IV
d: 3 IVs; 2 levels for the first IV; 3 levels for the second IV; 4 levels for the third IV
e: 4 IVs; 2 levels for the first IV; 2 levels for the second IV; 2 levels for the third IV; 2 levels for the fourth IV



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library